Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Edwards Lifesciences and Meril have been fighting over heart-valve technology for years. Now the EPO has finally destroyed one of Edwards' patents. The parallel infringement proceedings at the Munich
On 10 December, European Patent Office (EPO) President António Campinos and Ana Bandeira, President of the Directive Council of the Portuguese Institute of Industrial Property (INPI), concluded a
Starting 1 December 2024, applicants with successful outcomes from the Intellectual Property Office of New Zealand (IPONZ) can benefit from expedited processing at the European Patent Office (EPO
The EPO Opposition Division has upheld a CRISPR/Cas9 patent belonging to the University of California (Berkeley), University of Vienna, and Emmanuelle Charpentier, following a 15-hour hearing.
With a just-released report, the European Patent Office (EPO) continues its patent insight reports focusing on quantum technologies. The latest report provides an overview of important patent trends
As a result of the PPH pilot programme that started in January 2020, both Indecopi Peru (Insituto Nacional de Defensa de la Competencia y de la protección de la Propiedad Intelectual) and the EPO
Taking advantage of the Assemblies of the Member States of WIPO, INAPI Chile, and the EPO have signed a Reinforced Partnership Memorandum of Understanding (MoU) for 5 years. The EPO establishes
decision – at the EPO or in the German courts. But its counteroffensive cannot be written off yet. In fact, three other asserted patents, which it has in-licensed from Huawei, are posing more problems
On September 26, the European Patent Office (EPO) made the decision that OPPO's EP3624524 patent on "wireless communication methods, network device, and terminal device", which was challenged by
The EPO Boards of Appeal have revoked several patents belonging to Nevro, following oppositions from competitors Boston Scientific and Medtronic. While two of the companies had previously settled all
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
